DE69808455T2 - Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen - Google Patents

Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen

Info

Publication number
DE69808455T2
DE69808455T2 DE69808455T DE69808455T DE69808455T2 DE 69808455 T2 DE69808455 T2 DE 69808455T2 DE 69808455 T DE69808455 T DE 69808455T DE 69808455 T DE69808455 T DE 69808455T DE 69808455 T2 DE69808455 T2 DE 69808455T2
Authority
DE
Germany
Prior art keywords
heparine
molecular weights
lower molecular
treating brain
brain edemas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69808455T
Other languages
English (en)
Other versions
DE69808455D1 (de
Inventor
Veronique Mary
Jeremy Pratt
Jean-Marie Stutzmann
Andre Uzan
Florence Wahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE69808455D1 publication Critical patent/DE69808455D1/de
Publication of DE69808455T2 publication Critical patent/DE69808455T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE69808455T 1997-05-28 1998-05-25 Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen Expired - Lifetime DE69808455T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706551A FR2763849B1 (fr) 1997-05-28 1997-05-28 Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux
PCT/FR1998/001035 WO1998053834A1 (fr) 1997-05-28 1998-05-25 Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux

Publications (2)

Publication Number Publication Date
DE69808455D1 DE69808455D1 (de) 2002-11-07
DE69808455T2 true DE69808455T2 (de) 2003-07-03

Family

ID=9507336

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69808455T Expired - Lifetime DE69808455T2 (de) 1997-05-28 1998-05-25 Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen

Country Status (24)

Country Link
US (1) US6579858B1 (de)
EP (1) EP0984787B1 (de)
JP (1) JP2002502387A (de)
KR (1) KR100562425B1 (de)
CN (1) CN1223351C (de)
AT (1) ATE225181T1 (de)
AU (1) AU742995B2 (de)
BR (1) BR9809180A (de)
CA (1) CA2290682A1 (de)
DE (1) DE69808455T2 (de)
DK (1) DK0984787T3 (de)
ES (1) ES2182321T3 (de)
FR (1) FR2763849B1 (de)
IL (2) IL132670A0 (de)
MA (1) MA24554A1 (de)
NO (1) NO317003B1 (de)
NZ (1) NZ501366A (de)
PE (1) PE73099A1 (de)
PT (1) PT984787E (de)
RU (1) RU2195287C2 (de)
TN (1) TNSN98072A1 (de)
TW (1) TW546141B (de)
WO (1) WO1998053834A1 (de)
ZA (1) ZA984433B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787329B1 (fr) * 1998-12-17 2001-02-09 Aventis Pharma Sa Nouvelle application therapeutique des heparines de bas poids moleculaire
CA2458852A1 (en) * 2001-08-28 2003-03-06 Leo Pharma A/S Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.
US11840565B2 (en) 2016-12-29 2023-12-12 University Of Miami Methods and compositions for treating virus-associated inflammation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2013092C1 (ru) * 1989-02-27 1994-05-30 Дагестанский государственный медицинский институт Способ лечения отека мозга при туберкулезном менингоэнцефалите

Also Published As

Publication number Publication date
NO317003B1 (no) 2004-07-19
US6579858B1 (en) 2003-06-17
NO995539L (no) 1999-11-12
JP2002502387A (ja) 2002-01-22
CA2290682A1 (fr) 1998-12-03
BR9809180A (pt) 2000-08-01
CN1257429A (zh) 2000-06-21
NZ501366A (en) 2000-11-24
PT984787E (pt) 2003-01-31
CN1223351C (zh) 2005-10-19
WO1998053834A1 (fr) 1998-12-03
KR20010013073A (ko) 2001-02-26
TNSN98072A1 (fr) 2005-03-15
MA24554A1 (fr) 1998-12-31
PE73099A1 (es) 1999-10-21
EP0984787B1 (de) 2002-10-02
AU742995B2 (en) 2002-01-17
IL132670A (en) 2010-05-31
AU7776098A (en) 1998-12-30
ATE225181T1 (de) 2002-10-15
NO995539D0 (no) 1999-11-12
FR2763849B1 (fr) 2000-09-15
ES2182321T3 (es) 2003-03-01
FR2763849A1 (fr) 1998-12-04
EP0984787A1 (de) 2000-03-15
IL132670A0 (en) 2001-03-19
TW546141B (en) 2003-08-11
ZA984433B (en) 1998-12-28
DE69808455D1 (de) 2002-11-07
DK0984787T3 (da) 2003-02-03
RU2195287C2 (ru) 2002-12-27
KR100562425B1 (ko) 2006-03-17

Similar Documents

Publication Publication Date Title
ATE207356T1 (de) Verwendung von tiagabin zur behandlung von schlafstörungen
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE69726724D1 (de) Tetrahydropteridine und pyridylpiperazine zur behandlung von neurologischen störungen
ATE221358T1 (de) Verbandssystem
DE69736183D1 (de) Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
ATE225176T1 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
ATE215822T1 (de) Verwendung von rapamycin zur behandlung von anämie
DE69834724D1 (de) Behandlung von Darm- oder Blasenentzündungen
DE69808455T2 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
ATE97803T1 (de) Therapeutische verwendung von 5-ht3-rezeptorantagonisten.
DE69429013D1 (de) Verwendung von dimeticon zur behandlung der konstipation
DE69919578D1 (de) VERWENDUNG von NIEDERMOLEKULAREM HEPARIN zur Behandlung und/oder Prophylaxe motoneuronaler Krankheiten
ATE216884T1 (de) Verwendung von sulbutiamin zur behandlung von psychomotorischen oder psychointellektuellen beschwerden
DK0900085T3 (da) Behandling af overdreven aggression med olanzapin
DE69802828D1 (de) Verwendung von 6,7-substituierter 2-aminotetraline zur behandlung von zytokin-vermittleten entzündungszuständen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC